Abbott India Ltd

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. More about the company

₹26,000
+1.64% today
₹55,248 Cr · Large cap
Market Neutral — FadingHealth Care 44.6% in Stage 2-2.6 pts / 20dPharmaceuticals 51.3%-0.4 pts

Pro read

Pro

Our read

Not enough history to read yet

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is ABBOTINDIA early, or has it already run? Pro answers that for every NSE stock, after every close.

₹2,999 · 12 months₹1,999 · 6 months
Loading price chart…
vs 52W High
—
Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.
Stage Maturity
Week 27
1w13w26w
Week 27 — mature, watch for distribution
How long this stock has been basing. Longer bases can produce stronger breakouts — but don't anticipate, wait for the breakout.
vs 200 DMA
—
—
Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.
Rel Volume
0.40x
vs 50-day avg
Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.
Trend Health
↗ ⇈
Accelerating · MA20 +1.1% vs MA50 -1.5% / 10d
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
+1.7%
3M
-4.3%
6M
+0.6%
YTD
—
1Y
—
Sector
Health Care
↓ Peaking
Stage 2%
44.6%
20d Δ
-2.6pp
1M return
-4.9%
3M return
+0.2%
Sector Stage-2 % · last 20 days
Sector has 74 Stage 2 leaders. See Health Care Stage 2 →
Industry
Pharmaceuticals
→ Flat
Stage 2%
51.3%
20d Δ
-0.4pp
1M return
-4.2%
3M return
-0.6%
Industry Stage-2 % · last 20 days
Industry has 58 Stage 2 leaders. See Pharmaceuticals Stage 2 →
Stage Cycle Timeline2026-04-02 → 2026-10-09
S? 27w
2026-04-022026-10-09
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 27w current
Total tracked: 27 weeks across 1 stage run.
Scan Membership
Not in any current scan.
Recent Stage Timeline
2026-10-09S—
Wk 27 · Vol 0.40x
2026-10-08S—
Wk 27 · Vol 0.64x
2026-10-07S—
Wk 27 · Vol 1.04x
2026-10-06S—
Wk 26 · Vol 1.46x
2026-10-05S—
Wk 26 · Vol 0.65x
2026-10-01S—
Wk 26 · Vol 0.75x
2026-09-30S—
Wk 26 · Vol 0.60x
2026-09-29S—
Wk 26 · Vol 2.25x
2026-09-28S—
Wk 25 · Vol 0.59x
2026-09-25S—
Wk 25 · Vol 0.24x
2026-09-24S—
Wk 25 · Vol 0.47x
2026-09-23S—
Wk 25 · Vol 0.46x
Sector Peers — Stage 2All →
BAFNAPH
wk 18 · 0.0% from hi
8.6
ZIMLAB
wk 22 · 0.0% from hi
8.3
KILITCH
wk 2 · -7.3% from hi
8.3
SMSPHARMA
wk 3 · -8.0% from hi
8.3
RPGLIFE
wk 16 · -12.0% from hi
7.6
Moving averages & range
50 DMA
₹26,660.8
200 DMA
—
52W High
—
52W Low
—
5D Low
₹25,580
Resistance levels (recent highs)
20d High
₹27,270
60d High
₹28,900
120d High
₹28,900
250d High
—
Next resistance
+4.9%
to 20d High
Ask the Market AI about ABBOTINDIAAsk →
P/E (TTM)
37.9
Forward 30.5
Earnings Growth (YoY)
+7.6%
Revenue +6.5%
ROE
+34.5%
Profit margin +22.4%
Dividend Yield
1.90%
P/B 12.3
About this companyHealth Care· Pharmaceuticals

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, neuro-psychiat, pain management, respiratory, hepatic, neuroscience, metabolics, gennext, and consumer care products. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited operates as a subsidiary of Abbott Capital India Limited.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-09. Past data patterns are not indicative of future results. This page is a data analytics tool only.